CASC
BLU

Coppell Advisory Solutions Corp’s BELLUS Health Inc. BLU Stock Holding History

Coppell Advisory Solutions Corp’s Portfolio BLU Stock Details BLU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-79
Closed -$649 – 1187
2022
Q4 		$649 Buy
+79
New +$737 ﹤0.01% 988

Other funds holding BLU

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PCOC
Power Corp of Canada Montreal, Quebec, Canada $745M AUM 22.7% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Coppell Advisory Solutions Corp's BLU Position: Q1 2023 in Review

Coppell Advisory Solutions Corp sold out of BELLUS Health Inc. (BLU) in Q1 2023, closing a stake of 79 shares — an estimated $649 sold.

Coppell Advisory Solutions Corp first reported a position in BLU in Q4 2022 and held it in 1 quarter. The position peaked at $649 in Q4 2022. 106 funds tracked by Wall St. Rank hold BLU as of Q1 2023.

  • Coppell Advisory Solutions Corp reported no remaining BELLUS Health Inc. position as of Q1 2023 after selling out during the quarter.
  • Coppell Advisory Solutions Corp sold 79 BELLUS Health Inc. shares in Q1 2023, an estimated $649.
  • Coppell Advisory Solutions Corp first reported a position in BELLUS Health Inc. in Q4 2022 and held it in 1 quarter.
  • Coppell Advisory Solutions Corp's BELLUS Health Inc. position peaked at $649 in Q4 2022.
  • 106 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q1 2023.

Based on Coppell Advisory Solutions Corp's 13F filing for Q1 2023, filed 10 May 2023.